
Pharmacognosy Practical D Pharm
1. Morphological Identification of the following drugs:
Ispaghula, Senna, Coriander, Fennel, Cardamom, Ginger, Nutmeg, Black Pepper, Cinnamon, Clove, Ephedra, Rauwolfia, Gokhru, Punarnava, Cinchona, Agar.
2. Gross anatomical studies (Transverse Section) of the following drugs:
Ajwain, Datura, Cinnamon, Cinchona, Coriander, Ashwagandha, Liquorice, Clove, Curcuma, Nux vomica, Vasaka
3. Physical and chemical tests for evaluation of any FIVE of the following drugs:
- Asafoetida,
- Benzoin,
- Pale catechu,
- Black catechu,
- Castor oil,
- Acacia,
- Tragacanth,
- Agar,
- Guar gum,
- Gelatine.
Assignments
The students shall be asked to submit the written assignments on the following topics (One assignment per student per sessional period. i.e., a minimum of THREE assignments per student)
1. Market preparations of various dosage forms of Ayurvedic, Unani, Siddha, Homeopathic (Classical and Proprietary), indications, and their labelling requirements
2. Market preparations of various herbal formulations and herbal cosmetics, indications, and their labelling requirements
3. Herb-Drug interactions documented in the literature and their clinical significance
Field Visit
The students shall be taken in groups to a medicinal garden to witness and understand the nature of various medicinal plants discussed in theory and practical courses. Additionally, they shall be taken in groups to the pharmacies of traditional systems of medicines to understand the availability of various dosage forms and their labelling requirements. Individual reports from each student on their learning experience from the field visit shall be submitted.
F Y D Pharm & S Y D Pharm Notes, Books, Syllabus, PDF, Videos
Suggested readings
Recommended readings:
Data Management in AI-Enabled Medical Devices: Key to Safety and Effectiveness
As artificial intelligence (AI) reshapes the landscape of medical technology, data management has emerged as a cornerstone of ensuring the reliability, safety, and equity of AI-enabled medical devices. The U.S. Food and Drug Administration (FDA) underscores the importance of robust data management practices in its draft guidelines for AI-enabled device software functions (AI-DSFs). These recommendations…
Risk Management in AI-Enabled Medical Devices: A Critical Pillar of FDA Guidelines
The integration of artificial intelligence (AI) into medical devices brings remarkable possibilities, from enhancing diagnostic accuracy to streamlining treatment processes. However, with these advancements come inherent risks that must be carefully identified and mitigated. Recognizing this, the U.S. Food and Drug Administration (FDA) emphasizes the importance of robust risk management strategies in its draft guidelines…
Clarifying Device Description and Intended Use in AI-Enabled Medical Devices
Artificial intelligence (AI) has emerged as a transformative force in medical technology. From diagnostics to treatment planning, AI-enabled devices are redefining healthcare delivery. To ensure the safe and effective use of these devices, the U.S. Food and Drug Administration (FDA) has provided draft guidelines emphasizing the importance of device description and intended use in AI-enabled…


